Migraine patients. Other specified cerebrovascular diseases
Conditions
Interventions
Intervention 1: Intervention group: Dry needling. Intervention 2: Intervention group: Soft tissue release. Intervention 3: Control group: Placebo control.
Sponsors
University of social welfare and rehabilitation sciences
Eligibility
Sex/Gender
All
Age
25 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. A neurologist selected the study subjects based on IHS criteria for diagnosis of migraine. 2. The patients in this study were between the ages of 25 and 55 years old The patients with migraine were examined to find any active trigger points in UT, SCM, sub-occipital muscles . The presence of active trigger points was confirmed if “1- There was an area of focal muscle tenderness that was activated by palpation and that, when activated, referred pain replicating the patient’s headache complaint. 2- There was a jump sign that was the characteristic behavioral response to pressure on a trigger point” . One diagnostic test in particular, the flexion–rotation test, is said to determine C1-2 dysfunction .Patient was supine position. With the subject relaxed and the cervical spine is fully flexed with the occiput resting against the examiners. The head is then rotated to the left and the right. If firm resistance is percieved, pain provoked and range is limited before the expected end range .The normal range is reported at 44-45 degrees, therefore, the test is positive when the range of motion is more than 10 degrees from the normal range.Studies have shown that migraine has a small effect on the range of motion during this test, but this test shows the presence or absence of cervicogenic headache and this test can use for Differential Diagnosis between migraine headache and cervicogenic headache.The positive test indicates a cervicogenic headache
Exclusion criteria
Exclusion criteria: history of cervical disc herniation, unusual migraine, heart failure, pulmonary failure, kidney failure, liver failure, circulation failure, diabetes mellitus patients who were using opioid prophylaxis, anti -depressant, anti-anxiety drugs subjects who were pregnant or breastfeeding and Those who having trigger point therapy within the past month before the study The patients, who underwent DN, had no contraindication for needling such as local infection, pregnancy with threatened abortion, taking anticoagulants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 2-Headache intensity. Timepoint: Before,After and 1month follow up. Method of measurement: Daily note form.;3-Headache duration. Timepoint: Before,After and 1month follow up. Method of measurement: Daily note form.;Number of drug consumption. Timepoint: Before,After and 1month follow up. Method of measurement: Daily note form.;1-Headache frequency. Timepoint: Before,After and 1month follow up. Method of measurement: Daily note form. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Pressure pain threshold. Timepoint: Before, After and 1month follow up. Method of measurement: Algometer.;2-Muscle thickness. Timepoint: Before, After and 1month follow up. Method of measurement: Ultrasonography.;3-Range of motion. Timepoint: Before, After and 1month follow up. Method of measurement: Goniometer.;4-Neck disability index. Timepoint: Before, After and 1month follow up. Method of measurement: Neck disability index questionnaire.;5-Head disability index. Timepoint: Before, After and 1month follow up. Method of measurement: Head disability index questionnaire.;6-Pain intensity. Timepoint: Before, After and 1month follow up. Method of measurement: Visual analog scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTahere Rezaeian
University of social welfare and rehabilitation sciences
Outcome results
None listed